11/07/2013 18:45:00

U.K. Recalls Drugs Made in India

LONDON--In another sign of possible manufacturing problems in India's pharmaceutical industry, the U.K.'s medicines regulator said it was recalling 16 drugs made by Wockhardt Ltd. (532300.BY) after finding "manufacturing deficiencies" at one of the company's factories in India.

The Medicines and Healthcare products Regulatory Agency, or MHRA, called it a "precautionary recall," as there is no evidence that the medicines are defective. The agency said it is recalling the drugs from pharmacies and wholesalers but isn't asking patients to return their Wockhardt medicines.

"There is no evidence of a patient safety risk. ...however, the MHRA has to act in the interest of public health as poor manufacturing standards cannot be allowed to continue," the agency said.

The recalled drugs, manufactured in the central Indian city of Waluj, include treatments for infections, hypertension, diabetes, epilepsy and other diseases. The MHRA said the plant suffered from "poor cleaning practices" and defective ventilation systems. The agency inspection also found evidence of "forged documents relating to staff training records."

In an emailed statement, Wockhardt confirmed the news and said the recall would result in a one-time charge of 1.5 million pounds ($2.25 million) this year. Exports from the Waluj plant constitute less than 5% of the company's total U.K. sales and less than 2% of overall sales, it added.

It was the second recent setback for the company and its Waluj factory. In May, the U.S. Food and Drug Administration imposed an import ban on products from the factory after it failed an FDA safety inspection. The FDA didn't elaborate on the problems it found.

In a conference call at the time, Wockhardt Chairman Habil Khorakiwala said the company was implementing "corrective measures to be in compliance with the FDA guidelines." He said the U.S. import ban could cost the company $100 million in revenue this fiscal year. Wockhardt generated total revenue of 25.6 billion rupees ($460.6 million) in the year ended March 31, 2012.

Also in May, India's Ranbaxy Laboratories Ltd. (500359.BY) agreed to pay $500 million in civil and criminal fines for exporting adulterated drugs to the U.S.

In a phone interview Thursday, D.G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry body, said the group has written to the FDA asking it to conduct workshops with Indian companies to correct erroneous practices.

"Companies need to better understand FDA processes, and there needs to be a correction in their organizational culture, right from drug discovery to development and production," Mr. Shah said.

Write to Jeanne Whalen at jeanne.whalen@wsj.com and Anirban Chowdhury at anirban.chowdhury@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

July 11, 2013 13:45 ET (17:45 GMT)

Copyright (c) 2013 Dow Jones & Company, Inc.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
21 Jun
OMXC20
  Jeg vil indlede dette Insight, som er kort, med at oplyse, at nederst i denne tekst har jeg indsat..
45
21 Jun
I:UKX
Hvis England stemmer for at forlade EU, hvad sker der så?   I første omgang vil pundet og aktiemarke..
38
24 Jun
I:SP500
Så lukkede S&P med et kraftigt dyk ned igennem 2.040 og ikke langt fra dagens laveste. 2.020 holdt s..
28
24 Jun
OMXC20
For dem, der har fulgt med i mine Insights, kommer det sikkert ikke som en stor overraskelse, at jeg..
26
25 Jun
 
Sad det meste af dage i går og fulgte Brexit på bl.a DR2, TV2 og SkyChannel. Ikke en eneste gang kom..
25
23 Jun
C:SXAUUSDOZ\SP
Skønt at se at en lille appetitvækker som den nedenfor, kan skabe så meget mudderkast og gylp. Herli..
24
22 Jun
I:DAX
Jeg smider lige en graf for at I kan se hvad der foregår, for I har vist stadig ikke rigtig fået pud..
18
25 Jun
I:SP500
Jeg synes lige jeg vil komme med et par kommentarer til dit indlæg. Ikke fordi jeg grundlæggende er ..
16
20 Jun
I:DAX
Jeg har kigget lidt nærmere på diverse indeks her til aften, og har følgende indspark.   Mandag kan ..
15
25 Jun
 
Nedenfor i 375606 blandede jeg min mening om EU med synspunkter om folkeafstemninger, det beklager j..
14

Alliance Trust PLC : Net Asset Value(s)

24/06/2016 14:11:21
ALLIANCE TRUST PLC                                    At the close of business on Thursday 23 June 2016: The Company's NAV per ordinary share,..

HSBC Bank Plc : Form 8.5 (EPT/RI) - London Stock Exchange Group Plc

24/06/2016 11:52:38
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY ..

Form 8.3 - J Sainsbury Plc

24/06/2016 10:58:27
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2016   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
26 June 2016 11:05:43
(UTC) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20160622.1 - EUROWEB7 - 2016-06-26 12:05:43 - 2016-06-26 11:05:43 - 1000 - Website: OKAY